IP Verse

Capsule Pharmaceutical Dosage Form Comprising A Suspension Formulation Of An Indolinone Derivative - EP2299987

PATENT ANALYSIS

Patent Details

Grant Date
Feb 21, 2018
Company
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Oppositions

GALENICUM HEALTH S.L.U.

GENERICS (U.K.) LIMITED

TEVA PHARMACEUTICAL INDUSTRIES LTD.

ZENTIVA GROUP, A.S.

More patents of Boehringer Ingelheim International Gmbh

EP2313087

EP3110449

EP3802922

Want to monitor this patent?

Feel free to send us a message here and we will get back to you